Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-04-24, Stock:JNJ, The news for the past five days is as follows:
2020-04-17: NEWS1: A Covid-19 Vaccine Could Take Longer Than Investors Expect. Here’s Why..NEWS2: J&J and P&G, in Raising Their Dividends, Buck the Broader Trend.NEWS3: Q1 Earnings Scorecard and Analyst Reports for Netflix, Costco & Others.NEWS4: U.S., European health agencies to partner drugmakers in coronavirus fight.NEWS5: Senator Ted Cruz on Coronavirus Testing and Reopening the U.S. Economy.NEWS6: Pharma Stock Roundup: JNJ's Q1 Earnings, Coronavirus Product Development Efforts.NEWS7: Institutional investors tell Big Pharma to cooperate on coronavirus.NEWS8: Drug trial specialists see coronavirus-fueled spike in demand for virtual services.NEWS9: Johnson & Johnson execs offer upbeat view of second-half recovery from COVID-19 pandemic.
2020-04-20: NEWS1: Video- Back to Basics: Dividend Investing.NEWS2: Market Recap: Monday, April 20.NEWS3: Johnson & Johnson's Diversified Business Serves It Well in Uncertain Times.NEWS4: 4 Top Sectors of Last Week & Their Winning ETFs.NEWS5: Back-to-Back Weekly Gains as Stocks Continue to Recover.NEWS6: 5 Best Leveraged ETF Areas of Last Week.NEWS7: RPT-BUZZ-U.S. stocks weekly: Roadmap.NEWS8: RPT-Drug trial specialists see coronavirus-fueled spike in demand for virtual services.
2020-04-21: NEWS1: U.S. replaces director of agency overseeing COVID-19 vaccines, drugs.
2020-04-22: NEWS1: Hedge Funds’ This Stock Pick Debunked Naysayers.NEWS2: Johnson & Johnson Lifted to Buy as Outperformer in `Difficult Times'.NEWS3: These 'Healthy' Stocks Tip The Coronavirus Market In Your Favor.NEWS4: AbbVie Gets FDA Nod for Imbruvica+Rituxan in First-Line CLL.
2020-04-23: NEWS1: Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company's Goal to Supply More Than One Billion Vaccine Doses Globally.NEWS2: 21% tested positive for coronavirus antibodies in NYC, Cuomo says .NEWS3: Johnson & Johnson: Full Recovery in Sight.NEWS4: Is ISRG Stock A Buy After Coronavirus Slammed Quarterly Growth?.NEWS5: The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt.

Answer: Decrease